uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
MyD88-dependent toll-like receptor signalling is not a requirement for fetal islet xenograft rejection in mice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
2004 (English)In: Xenotransplantation, ISSN 0908-665X, E-ISSN 1399-3089, Vol. 11, no 4, 347-352 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Rejection of pancreatic islet xenografts in mice shares immunopathological features with a Th1-associated delayed-type hypersensitivity (DTH) reaction. The aim of the present study was to investigate the mechanism of acute cellular xenograft rejection in a strain of mice with a targeted gene disruption of the toll-like receptor (TLR) signal adaptor protein MyD88. These mice have been shown to have markedly impaired Th1 immunity.

METHODS: The MyD88-/- and normal mice were transplanted with 2 microl of fetal porcine islet-like cell clusters (ICC) under the left kidney capsule. On days 3, 6 or 12 after transplantation the mice were killed and the grafts either prepared for immunohistochemistry or real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR). The number of remaining ICC and infiltrating cells with different phenotypic characteristics was assessed semi-quantitatively. Grafts used for quantitative RT-PCR were analysed for content of murine mRNA of interferon (IFN)-gamma, interleukin (IL)-12p40, IL-4 and IL-10.

RESULTS: On day 3, the rejection process was initiated in both MyD88-/- and normal mice as characterized by a moderate infiltration of F4/80+ and MAC-1+ macrophages and occasional CD3+ and CD4+ cells. Expression of IFN-gamma and IL-12p40 was lower but still detectable in the MyD88-/- mice, when compared with control animals. By day 6, rejection was almost completed in all animals with only few ICC remaining. 12 days after transplantation all grafts were completely destroyed and heavily infiltrated by macrophages. Moderate numbers of CD3+ and CD4+ and occasional CD8+ cells were also present.

CONCLUSIONS: Islet xenograft rejection was found to persist in MyD88-/- mice. Despite a relatively lower expression of the Th1-associated cytokines IFN-gamma and IL12-p40 within the xenograft area, both the time course and morphological pattern of the rejection were essentially similar to that found in normal animals. Hence, MyD88-dependent TLR signalling does not appear to be a crucial component of acute cellular xenograft rejection

Place, publisher, year, edition, pages
2004. Vol. 11, no 4, 347-352 p.
Keyword [en]
Adaptor Proteins; Signal Transducing, Animals, Antigens; Differentiation/genetics/*metabolism, Cytokines/genetics/immunology, Fetus/*cytology/immunology, Graft Rejection/*immunology, Immunohistochemistry, Islets of Langerhans Transplantation/*immunology, Kinetics, Membrane Glycoproteins/*metabolism, Mice, Myeloid Differentiation Factor 88, RNA; Messenger/genetics/metabolism, Receptors; Cell Surface/*metabolism, Receptors; Immunologic/deficiency/genetics/*metabolism, Signal Transduction, Swine, Toll-Like Receptors, Transplantation; Heterologous/*immunology
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-25714DOI: 10.1111/j.1399-3089.2004.00145.xPubMedID: 15196129OAI: oai:DiVA.org:uu-25714DiVA: diva2:53488
Available from: 2007-02-13 Created: 2007-02-13 Last updated: 2017-12-07Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15196129&dopt=Citation

Authority records BETA

Schmidt, PeterKorsgren, Olle

Search in DiVA

By author/editor
Schmidt, PeterKorsgren, Olle
By organisation
Department of Oncology, Radiology and Clinical Immunology
In the same journal
Xenotransplantation
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 605 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf